This study of MCF-7 and SKBR-3 breast cancer, which reflects the patients with ER+ and HER2+ breast cancer, respectively, and may contribute and provide new insights into new therapeutics that are about to influence both the biochemical and biomechanical responses of cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.